发明名称 LAQUINIMOD COMBINATION THERAPY FOR TREATMENT OF MULTIPLE SCLEROSIS.
摘要 The subject invention provides a method for treating a subject afflicted with a form of multiple sclerosis (MS) or presenting a clinically isolated syndrome (CIS) comprising periodically administering to the subject an amount of laquinimod and an amount of a compound of formula (I) : as described herein. The subject invention also provides packages and pharmaceutical compositions comprising laquinimod and a compound of formula (I) as described herein. The subject invention further provides uses of said compounds, pharmaceutical compositions and packages in treating a subject afflicted with a form of MS or presenting a CIS.
申请公布号 MX2016003763(A) 申请公布日期 2016.10.28
申请号 MX20160003763 申请日期 2014.09.26
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 Joel KAYE;Volker KNAPPERTZ
分类号 A61K31/225 主分类号 A61K31/225
代理机构 代理人
主权项
地址